In addition, trNK cells displayed significantly higher proportions of the activating receptor NKG2C as compared to non-trNK cells, in both patient groups, implying a complex role of the TME on tumor-associated NK cell signature, especially in MSI patients where NKG2C+ trNK cells are more present compared to MSS. Here, KLRC2 is linked to neoplasm.